PharmiWeb

SK Capital Announces Definitive Agreement to Invest in Swixx BioPharma AG to Drive the Next Phase of Growth and Global Expansion

SK Capital Partners, LP (“SK Capital”), a New York-based private investment firm focused on the life sciences, specialty materials, and ingredients sectors, today announced that its affiliate has ...
PharmiWeb

IGC Pharma Positions as a Singular Beneficiary of Emerging Federal Momentum Toward Schedule III Cannabinoid Medicines

POTOMAC, MARYLAND / ACCESS Newswire / December 15, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company"), a clinical-stage biotechnology company leveraging Artificial Intelligence (AI) ...
PharmiWeb

Aytu BioPharma Announces Commercial Availability of EXXUA(TM) (gepirone) Extended-Release Tablets, the First and Only 5HT1a Agonist Indicated for the Treatment of Major ...

EXXUA is now available through Aytu RxConnect® pharmacies to ensure optimal access and availabilityEXXUA has demonstrated significant improvement in depression symptoms in clinical trials involving ...
PharmiWeb

Medical Care Technologies, Inc. (OTC Pink:MDCE) Completes First AI Consumer App Targeting Deployment Across 100+ Countries and 30 Languages

Dollar Global Food Market While Advancing Medical AI Pipeline MESA, ARIZONA / ACCESS Newswire / December 15, 2025 / Medical Care Technologies, Inc. (OTC Pink:MDCE) today announced the completion of ...
PharmiWeb

Global Minimally Invasive Surgery Market to Reach US$211.24 Billion by 2033, Says FutureWise Research

FutureWise Research, a leading provider of strategic market intelligence, has published an in-depth new market analysis ...
PharmiWeb

Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal ...

SBS-IF is the second orphan disease target indication for Jaguar's intestinal failure program, which includes microvillus inclusion disease (MVID) - for which the company completed a meeting in ...
PharmiWeb

GENESIS Pharma announces a new partnership with Otsuka Pharmaceutical Europe Ltd. for the commercialization of donidalorsen for hereditary angioedema in Central and Eastern Europe

ANNOUNCEMENT FOR EUROPEAN MEDICAL & PHARMACEUTICAL TRADE MEDIA AND EUROPEAN FINANCIAL MEDIA ONLYGENESIS Pharma, a regional biopharma company focused on the commercialization of innovative medicines in ...
PharmiWeb

EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's mNEXSPIKE (COVID-19 Vaccine, mRNA)

NEXSPIKE is Moderna's third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and mRESVIA (Respiratory Syncytial Virus Vaccine)mNEXSPIKE will be available in the ...
PharmiWeb

Multi Sciences Elevates Research Access with Global Bioz Badges Roll-out

PALO ALTO, CALIFORNIA / ACCESS Newswire / December 15, 2025 / Bioz, Inc., the leading AI-powered engine for scientific product insights, proudly announces the deployment of 1,000 Bioz Badges on Multi ...
PharmiWeb

Amphastar Announces FDA Approval for Teriparatide Injection

RANCHO CUCAMONGA, CA / ACCESS Newswire / December 15, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's ...
PharmiWeb

Sub-Saharan Africa Pharmaceuticals Market Industry Analysis , Opportunity Assessment And Forecast Till 2030: Medi-tech Insights

Sub-Saharan Africa Pharmaceuticals Market OutlookThe Sub-Saharan Africa (SSA) pharmaceuticals market is poised for strong expansion over the coming years, reflecting the region’s evolving healthcare ...
PharmiWeb

Atherectomy Devices Market to Witness a Leap by Leaching CAGR of 8% By The End Of 2029

Global Atherectomy Devices Market OverviewThe global atherectomy devices market is expected to witness substantial growth, with a projected CAGR of around 8% during the forecast period. Several key ...